Method of identifying natural antibodies for remyelination

Arthur E. Warrington, Moses Rodriguez

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction Natural autoantibodies are part of the normal human immunoglobulin repertoire. These antibodies react to self-antigens, are usually polyreactive with relatively low affinity, and typically are of the IgM isotype. Natural IgMs in mice that stimulated remyelination in central nervous system (CNS) demyelinating disease all shared the characteristics of binding to the surface of live oligodendrocytes and myelinated tracts in living slices of CNS tissue. Methods A screen for human IgMs with similar character resulted in two human natural antibodies,which when injected peripherally into animal models of demyelination induced remyelination. A recombinant human IgM (rHIgM22) that also promoted remyelination in vivo was constructed. Results Very small doses of this IgM are required for the promotion of remyelination (EC50 is 460 ng per 20-g mouse).It is clear that after peripheral delivery, rHIgM22 enters the CNS and accumulates in CNS lesions. rHIgM22 was tracked in living mice using ferritin-labeled antihuman mu chain antibodies visualized by magnetic resonance imaging and traditional immunocytochemistry. Although the exact antigen recognized by rHIgM22 is not known, all mouse IgMs that promote remyelination bind to myelin membrane lipids, suggesting the antigen for rHIgM22 is similar. Conclusions We propose that the IgMs bind to CNS cells and reorganize the membrane, initiating a signal that results in oligodendrocyte proliferation and/or protection with an end result of increased myelin. Recombinant natural human antibodies are potentially important therapeutic molecules that may modulate a wide spectrum of human disease.

Original languageEnglish (US)
JournalJournal of Clinical Immunology
Volume30
Issue numberSUPPL. 1
DOIs
StatePublished - May 2010

Fingerprint

Antibodies
Central Nervous System
Immunoglobulin M
Oligodendroglia
Demyelinating Diseases
Myelin Sheath
Antigens
Nerve Tissue
Central Nervous System Diseases
Autoantigens
Ferritins
Membrane Lipids
Autoantibodies
Immunoglobulins
Animal Models
Immunohistochemistry
Magnetic Resonance Imaging
Cell Membrane
Therapeutics

Keywords

  • Multiple sclerosis
  • Recombinant human antibodies
  • Remyelination
  • Theiler's murine encephalomyelitis virus

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Medicine(all)

Cite this

Method of identifying natural antibodies for remyelination. / Warrington, Arthur E.; Rodriguez, Moses.

In: Journal of Clinical Immunology, Vol. 30, No. SUPPL. 1, 05.2010.

Research output: Contribution to journalArticle

Warrington, Arthur E. ; Rodriguez, Moses. / Method of identifying natural antibodies for remyelination. In: Journal of Clinical Immunology. 2010 ; Vol. 30, No. SUPPL. 1.
@article{f99cfed18f6a4bb1a0025722fb13b04b,
title = "Method of identifying natural antibodies for remyelination",
abstract = "Introduction Natural autoantibodies are part of the normal human immunoglobulin repertoire. These antibodies react to self-antigens, are usually polyreactive with relatively low affinity, and typically are of the IgM isotype. Natural IgMs in mice that stimulated remyelination in central nervous system (CNS) demyelinating disease all shared the characteristics of binding to the surface of live oligodendrocytes and myelinated tracts in living slices of CNS tissue. Methods A screen for human IgMs with similar character resulted in two human natural antibodies,which when injected peripherally into animal models of demyelination induced remyelination. A recombinant human IgM (rHIgM22) that also promoted remyelination in vivo was constructed. Results Very small doses of this IgM are required for the promotion of remyelination (EC50 is 460 ng per 20-g mouse).It is clear that after peripheral delivery, rHIgM22 enters the CNS and accumulates in CNS lesions. rHIgM22 was tracked in living mice using ferritin-labeled antihuman mu chain antibodies visualized by magnetic resonance imaging and traditional immunocytochemistry. Although the exact antigen recognized by rHIgM22 is not known, all mouse IgMs that promote remyelination bind to myelin membrane lipids, suggesting the antigen for rHIgM22 is similar. Conclusions We propose that the IgMs bind to CNS cells and reorganize the membrane, initiating a signal that results in oligodendrocyte proliferation and/or protection with an end result of increased myelin. Recombinant natural human antibodies are potentially important therapeutic molecules that may modulate a wide spectrum of human disease.",
keywords = "Multiple sclerosis, Recombinant human antibodies, Remyelination, Theiler's murine encephalomyelitis virus",
author = "Warrington, {Arthur E.} and Moses Rodriguez",
year = "2010",
month = "5",
doi = "10.1007/s10875-010-9406-5",
language = "English (US)",
volume = "30",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Method of identifying natural antibodies for remyelination

AU - Warrington, Arthur E.

AU - Rodriguez, Moses

PY - 2010/5

Y1 - 2010/5

N2 - Introduction Natural autoantibodies are part of the normal human immunoglobulin repertoire. These antibodies react to self-antigens, are usually polyreactive with relatively low affinity, and typically are of the IgM isotype. Natural IgMs in mice that stimulated remyelination in central nervous system (CNS) demyelinating disease all shared the characteristics of binding to the surface of live oligodendrocytes and myelinated tracts in living slices of CNS tissue. Methods A screen for human IgMs with similar character resulted in two human natural antibodies,which when injected peripherally into animal models of demyelination induced remyelination. A recombinant human IgM (rHIgM22) that also promoted remyelination in vivo was constructed. Results Very small doses of this IgM are required for the promotion of remyelination (EC50 is 460 ng per 20-g mouse).It is clear that after peripheral delivery, rHIgM22 enters the CNS and accumulates in CNS lesions. rHIgM22 was tracked in living mice using ferritin-labeled antihuman mu chain antibodies visualized by magnetic resonance imaging and traditional immunocytochemistry. Although the exact antigen recognized by rHIgM22 is not known, all mouse IgMs that promote remyelination bind to myelin membrane lipids, suggesting the antigen for rHIgM22 is similar. Conclusions We propose that the IgMs bind to CNS cells and reorganize the membrane, initiating a signal that results in oligodendrocyte proliferation and/or protection with an end result of increased myelin. Recombinant natural human antibodies are potentially important therapeutic molecules that may modulate a wide spectrum of human disease.

AB - Introduction Natural autoantibodies are part of the normal human immunoglobulin repertoire. These antibodies react to self-antigens, are usually polyreactive with relatively low affinity, and typically are of the IgM isotype. Natural IgMs in mice that stimulated remyelination in central nervous system (CNS) demyelinating disease all shared the characteristics of binding to the surface of live oligodendrocytes and myelinated tracts in living slices of CNS tissue. Methods A screen for human IgMs with similar character resulted in two human natural antibodies,which when injected peripherally into animal models of demyelination induced remyelination. A recombinant human IgM (rHIgM22) that also promoted remyelination in vivo was constructed. Results Very small doses of this IgM are required for the promotion of remyelination (EC50 is 460 ng per 20-g mouse).It is clear that after peripheral delivery, rHIgM22 enters the CNS and accumulates in CNS lesions. rHIgM22 was tracked in living mice using ferritin-labeled antihuman mu chain antibodies visualized by magnetic resonance imaging and traditional immunocytochemistry. Although the exact antigen recognized by rHIgM22 is not known, all mouse IgMs that promote remyelination bind to myelin membrane lipids, suggesting the antigen for rHIgM22 is similar. Conclusions We propose that the IgMs bind to CNS cells and reorganize the membrane, initiating a signal that results in oligodendrocyte proliferation and/or protection with an end result of increased myelin. Recombinant natural human antibodies are potentially important therapeutic molecules that may modulate a wide spectrum of human disease.

KW - Multiple sclerosis

KW - Recombinant human antibodies

KW - Remyelination

KW - Theiler's murine encephalomyelitis virus

UR - http://www.scopus.com/inward/record.url?scp=77956182275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956182275&partnerID=8YFLogxK

U2 - 10.1007/s10875-010-9406-5

DO - 10.1007/s10875-010-9406-5

M3 - Article

VL - 30

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - SUPPL. 1

ER -